These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 737113)

  • 1. Assessment of atrophogenicity of popularly prescribed topical corticosteroids.
    Dykes PJ; Marks R; Blakemore CB
    Br J Clin Pract; 1978 Dec; 32(12):345-8. PubMed ID: 737113
    [No Abstract]   [Full Text] [Related]  

  • 2. The hairless mouse as a model for study of local and systemic atrophogenic effects following topical application of corticosteroids.
    van den Hoven WE; van den Berg TP; Korstanje C
    Acta Derm Venereol; 1991; 71(1):29-31. PubMed ID: 1676210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
    McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
    Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative animal experiments on epidermal hypoplasia induced by means of topical glucocorticoids].
    Weirich EG; Longauer J
    Z Hautkr; 1974 Feb; 49(3):91-106. PubMed ID: 4832936
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects and side-effects of locally administered corticosteroids].
    Rodermund OE
    Fortschr Med; 1975 Nov; 93(32):1600-6. PubMed ID: 130330
    [No Abstract]   [Full Text] [Related]  

  • 6. The hairless mouse model for assaying the atrophogenicity of topical corticosteroids.
    Woodbury R; Kligman AM
    Acta Derm Venereol; 1992 Nov; 72(6):403-6. PubMed ID: 1362829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for the assessment of skin atrophogenicity of topical corticosteroids.
    Marks R
    Dermatologica; 1976; 152 Suppl 1():117-26. PubMed ID: 133834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hazards of potent topical corticosteroids.
    Lancet; 1973 Apr; 1(7808):870-1. PubMed ID: 4123412
    [No Abstract]   [Full Text] [Related]  

  • 9. Current dangers and problems in the topical use of steroids.
    Deakin MJ
    Med J Aust; 1976 Jan; 1(5):120-1. PubMed ID: 772378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side effects of potent topical corticosteroids.
    Jackson R
    Can Med Assoc J; 1978 Jan; 118(2):173-4. PubMed ID: 93507
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucocorticoid action on skin collagen: overview on clinical significance and consequences.
    Nuutinen P; Autio P; Hurskainen T; Oikarinen A
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):361-2. PubMed ID: 11730056
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible side effects of topical steroids.
    Morman MR
    Am Fam Physician; 1981 Feb; 23(2):171-4. PubMed ID: 6450525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimized interval treatment of eczema with fluprednidene. A multicenter double-blind study].
    Mahrle G; Wemmer U; Matthies C
    Z Hautkr; 1989 Sep; 64(9):766-8, 773-4. PubMed ID: 2683439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atrophic striae].
    Resina O; Sotillo Gago I; Montes B; Castro R
    Actas Dermosifiliogr; 1975; 66(5-6):293-304. PubMed ID: 1163345
    [No Abstract]   [Full Text] [Related]  

  • 15. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
    Serup J; Holm P
    Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical corticosteroids.
    Pace WE
    Can Med Assoc J; 1973 Jan; 108(1):ll passim. PubMed ID: 4682644
    [No Abstract]   [Full Text] [Related]  

  • 17. [Animal experiment studies on the epidermal-hypoplastic effects of topical corticoids].
    Weirich EG; Longauer J
    Arztl Forsch; 1971 Sep; 25(9):292-8. PubMed ID: 5171203
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical adverse effects in the use of corticosteroids on the skin (topical treatment)].
    Wereide K
    Tidsskr Nor Laegeforen; 1976 Nov; 92(33):1750-2. PubMed ID: 996843
    [No Abstract]   [Full Text] [Related]  

  • 19. Skin atrophy of the eyelid induced by topical ophthalmic corticosteroids.
    Neittaanmäki H; Kontkanen M; Kallioinen M
    Acta Ophthalmol Scand; 1998 Jun; 76(3):372-3. PubMed ID: 9686858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysis.
    Kerscher MJ; Korting HC
    Skin Pharmacol; 1992; 5(2):77-80. PubMed ID: 1637562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.